American Peptide Company appoints two

Reflects ongoing commitment to provide better customer support

American Peptide Company, a US manufacturer of peptides and peptide-based services to the pharmaceutical and life science industries, has promoted Stewart Hamilton, who has its European sales representative since 2005, to sales and marketing director for the region.

In addition, Stuart White has joined the company as its US East Coast sales executive. White was most recently principal at Actif Bioresources, where he created supply networks dealing in products for therapeutic, mechanistic and academic studies.

‘The new appointments reflect the American Peptide Company’s ongoing commitment to providing better customer support and technical expertise to customers globally, helping them bring new drugs to market faster,’ said Takahiro Ogata, president and coo of American Peptide Company.

In December 2009, the company took on five new members of staff to enhance its technical capabilities.

You may also like

Ingredients

Bachem acquires American Peptide Company

No financial details have been disclosed
You need to be a subscriber to read this article.
Click here to find out more.
Ingredients

CPPs: beating drug delivery barriers

Cell-penetrating peptides are a promising tool for cellular import of drug cargos and have been applied in the delivery of a variety of therapeutic molecules. Jyothi Thundimadathil and Archana Gangakhedkar, American Peptide Co, highlight recent application studies
You need to be a subscriber to read this article.
Click here to find out more.
Ingredients

Bicyclic peptides for a new class of targeted drugs

Bicyclic peptides are an emerging class of molecules used to explore new cellular sites not treatable using small molecules or large antibodies. Archana Gangakhedkar, American Peptide Company, reveals some of the properties that offer a new route to targeting diseases
Manufacturing

American Peptide to expand manufacturing capacity at Vista

Move will enable APC to process large-scale peptide production and meet cGMP standards
You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing

Rice-ing to the occasion: how plant-based excipients are gaining ground in pharmaceutical manufacturing

As clean-label expectations migrate from health foods into pharmaceutical supply chains, natural ingredient supplier RIBUS says that rice-based excipients are becoming a credible alternative to synthetic standards
Ingredients

The impact of Brexit on raw materials testing for the pharmaceutical industry (2026 update)

Since the UK departed from the EU, the pharmaceutical regulatory landscape has undergone significant and lasting change; whereas early uncertainty has largely subsided, the system has evolved into a stable but more complex dual framework
Manufacturing

Cipla receives FDA approval for first AB-rated generic of Ventolin HFA in $1.5bn US albuterol market

Indian pharmaceutical company Cipla has secured final FDA approval for its Albuterol Sulfate Inhalation Aerosol, becoming the first AB-rated generic therapeutic equivalent of GlaxoSmithKline's Ventolin HFA
Subscribe now